Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at the omega (BZ) modulatory sites of GABAA receptors.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Neuropharmacology

• Publication date

  1992-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0028-3908(92)90148-IPMID 1357576
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Associative control of tolerance to the sedative and hypothermic effects of chlordiazepoxide

  2004cited by this paper
• Analysis of the role of drug-predictive environmental stimuli in tolerance to the hypothermic effects of the benzodiazepine midazolam

  2004cited by this paper
• The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic

  2004cited by this paper
• Learnt tolerance to sedative effects of chlordiazepoxide on self-stimulation performance, but no tolerance to facilitatory effects after 80 days

  2004cited by this paper
• A comparison between chlordiazepoxide and CL 218,872—a synthetic nonbenzodiazepine ligand for benzodiazepine receptors on spontaneous locomotor activity in rats

  2004cited by this paper
• Rapid development of tolerance to the sedative effects of lorazepam and triazolam in rats

  2004cited by this paper
• Potency of several type I-benzodiazepine receptor ligands for inhibition of [3H]flunitrazepam binding in different rat brain tissues.

  1991cited by this paper
• Gamma-aminobutyric acidA receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology.

  1990cited by this paper
• Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics.

  1990cited by this paper
• γ‐Aminobutyric AcidA Receptor α5‐Subunit Creates Novel Type II Benzodiazepine Receptor Pharmacology

  1990cited by this paper
• Behavioral analysis of zopiclone on the basis of their discriminative stimulus properties in the rat.

  1989cited by this paper
• Psychoactive Drugs

  1989cited by this paper
• In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype.

  1988cited by this paper
• LIMITATIONS OF THE BENZODIAZEPINE RECEPTOR NOMENCLATURE: A PROPOSAL FOR A PHARMACOLOGICAL CLASSIFICATION AS OMEGA RECEPTOR SUBTYPES

  1988cited by this paper
• The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure.

  1987cited by this paper
• Associative control of tolerance to the sedative effects of a short-acting benzodiazepine.

  1987cited by this paper
• Investigation of the development of tolerance to the actions of zolpidem and midazolam.

  1987cited by this paper
• Analysis of the role of behavioural factors in the development of tolerance to the benzodiazepine midazolam.

  1987cited by this paper
• Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.

  1986cited by this paper
• Tolerance to the behavioral actions of benzodiazepines.

  1985cited by this paper
• Pharmacological and clinical studies of cyclopyrrolones: zopiclone and suriclone.

  1984cited by this paper
• Pharmacological studies on zopiclone.

  1983cited by this paper
• Pharmacological studies on zopiclone.

  1982cited by this paper
• Development and retention of tolerance to the sedative effects of chlordiazepoxide: role of apparatus cues.

  1982cited by this paper
• Some properties of brain specific benzodiazepine receptors: new evidence for multiple receptors.

  1979cited by this paper
• A synthetic non-benzodiazepine ligand for benzodiazepine receptors: a probe for investigating neuronal substrates of anxiety.

  1979cited by this paper

• In vivo characterization of natural product GABAA modulators and their derivatives

  2015cites this paper
• The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: Comparison with diazepam

  2014cites this paper
• The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABAA receptors

  2014cites this paper
• The safetyand tolerabilityof zolpidemanupdate

  2013cites this paper
• Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABAA Receptor Modulators?

  2012cites this paper
• Nonhuman Primate Models of Drug and Alcohol Addiction

  2012cites this paper
• Sleeping through the night: Are extended‐release formulations the answer?

  2008cites this paper
• Novel discriminative stimulus effects of TPA023B, subtype-selective gamma-aminobutyric-acid(A)/benzodiazepine modulator: comparisons with zolpidem, lorazepam, and TPA023.

  2008cites this paper
• Treatment Options for Insomnia-Pharmacodynamics of Zolpidem Extended-Release to Benefit Next-Day Performance

  2008cites this paper
• Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care.

  2007cites this paper
• The value of nonhuman primates in drug abuse research.

  2007cites this paper
• Enhanced sucrose pellet consumption induced by benzodiazepine-type drugs in squirrel monkeys: role of GABAA receptor subtypes

  2006cites this paper
• Zopiclone Overdose Responsive to Flumazenil

  2005cites this paper
• Discriminative stimulus effects of ω (BZ) receptor ligands: correlation with in vivo inhibition of [3H]-flumazenil binding in different regions of the rat central nervous system

  2005cites this paper
• COX-2 Inhibitors

  2004cites this paper
• Impact of DHEA on GABA-agonist Challenge in Healthy Young and Older adults

  2003influential citation
• Molecular mechanisms of tolerance to and withdrawal of GABA(A) receptor modulators.

  2003cites this paper
• Behavioral effects of acute and chronic triazolam treatments in albino rats.

  2003cites this paper
• Differential Effects In Humans After Repeated Administrations Of Zolpidem And Triazolam

  2003cites this paper
• Antiaggressive Effects of Zolpidem and Zopiclone in Agonistic Encounters Between Male Mice

  2002cites this paper
• The effect of zolpidem on operant behavior and its relation to pharmacokinetics after intravenous and subcutaneous administration: concentration–effect relations

  2002cites this paper
• The e¡ect of zolpidem on operant behavior and its relation to pharmacokinetics after intravenous and subcutaneous administration: concentration^e¡ect relations

  2002influential citation
• Changes in GABA(A) receptor gene expression induced by withdrawal of, but not by long-term exposure to, zaleplon or zolpidem.

  2002cites this paper
• El efecto del zolpidem en los pacientes con insomnio de corta evolución

  2001cites this paper
• Antagonism of the discriminative stimulus effects of positive gamma-aminobutyric acid(A) modulators in rhesus monkeys discriminating midazolam.

  2000cites this paper
• Antagonism of the discriminative stimulus effects of positive γ-aminobutyric acid(A) modulators in rhesus monkeys discriminating midazolam

  2000cites this paper
• Non-benzodiazepines for the treatment of insomnia.

  2000cites this paper
• Precipitated and spontaneous withdrawal following administration of lorazepam but not zolpidem.

  2000cites this paper
• Subtype-selective benzodiazepine receptor ligands

  2000cites this paper
• Epidemiological Evidence for a Low Abuse Potential of Zolpidem

  2000cites this paper
• Zolpidem involvement on memory and hypnotic effect of ethanol in chronically ethanol-treated rats.

  1999cites this paper
• Efectos de la administración de midazolam sobre la conducta agonística en ratones machos

  1999cites this paper
• The safety and tolerability of zolpidemöan update

  1999cites this paper
• The safety and tolerability of zolpidemöan update

  1999influential citation
• The Pharmacology and Mechanism of Action of Zolpidem.

  1998cites this paper
• Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons.

  1998cites this paper
• The abuse potential of zolpidem administered alone and with alcohol.

  1998cites this paper
• Behavioral pharmacology of zolpidem relative to benzodiazepines: a review.

  1998cites this paper
• Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons.

  1998cites this paper
• Zolpidem is differentiated from triazolam in humans using a three-response drug discrimination procedure

  1998cites this paper
• Beyond Benzodiazepines: Alternative Pharmacologic Agents for the Treatment of Insomnia

  1998cites this paper
• Comparison of Continuous versus Intermittent Administration of Zolpidem in Chronic Insomniacs: A Double-Blind, Randomized Pilot Study

  1998cites this paper
• General safety profile of zolpidem: safety in elderly, overdose and rebound effects

  1997cites this paper
• The effects of new hypnotic drugs in rats trained to discriminate ethanol

  1997cites this paper
• Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers

  1997cites this paper
• Perfil de seguridad general de zolpidem en ancianos, sobredosis y efectos de rebote

  1996cites this paper
• Sensitization of gamma-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal.

  1996cites this paper
• Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem.

  1996cites this paper
• Assessment of benzodiazepine receptor heterogeneity in vivo: apparent pA2 and pKB analyses from behavioral studies

  1996cites this paper
• Next day effects after nighttime treatment with zolpidem: a review

  1996cites this paper
• Behavioral and biochemical characterization of benzodiazepine receptor partial agonists in pigeons.

  1996cites this paper
• State-dependent effects of atypical benzodiazepine-receptor agonists

  1995cites this paper
• Differential expression of benzodiazepine anticonvulsant cross-tolerance according to time following flurazepam or diazepam treatment.

  1995cites this paper
• Pharmacokinetics and brain distribution of zolpidem in the rat after acute and chronic administration

  1994cites this paper
• Tolerance, cross-tolerance and dependence measured by operant responding in rats treated with triazolam via osmotic pumps

  1994cites this paper
• Regional changes in [3H]zolpidem binding to brain benzodiazepine receptors in flurazepam tolerant rat: comparison with changes in [3H]flunitrazepam binding.

  1994cites this paper
• Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes.

  1994cites this paper
• Effects of chronic treatment with triazolam on operant responding in rats.

  1994cites this paper
• Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors.

  1993cites this paper
• Discriminative stimulus effects of omega (BZ) receptor ligands: correlation with in vivo inhibition of [3H]-flumazenil binding in different regions of the rat central nervous system.

  1993cites this paper
• Gamma-aminobutyric acidA receptor subunits in the mediation of selective drug action.

  1993cites this paper